Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Palisade Bio Inc shares valued at $4,692 were purchased by Finley John David on Feb 06 ’24. At $0.47 per share, Finley John David acquired 10,000 shares. The insider’s holdings grew to 84,649 shares worth approximately $0.6 million following the completion of this transaction.
Also, Williams Donald Allen purchased 10,000 shares, netting a total of over 6,050 in proceeds. Following the buying of shares at $0.60 each, the insider now holds 30,000 shares.
Before that, Finley John David had added 10,000 shares to its account. In a trade valued at $5,590, the CEO, CFO, Director bought Palisade Bio Inc shares for $0.56 each. Upon closing the transaction, the insider’s holdings increased to 10,000 shares, worth approximately $0.53 million.
Analyzing PALI Stock Performance
During the last five days, there has been a surge of approximately 11.50%. Over the course of the year, Palisade Bio Inc shares have dropped approximately -20.00%. Shares of the company reached a 52-week high of $22.35 on 01/29/24 and a 52-week low of $3.82 on 04/12/24. A 50-day SMA is recorded $5.72, while a 200-day SMA reached $9.89. Nevertheless, trading volume fell to 12.25 million shares from 55600.0 shares the previous day.
Support And Resistance Levels for Palisade Bio Inc (PALI)
According to the 24-hour chart, there is a support level at 5.93, which, if violated, would cause prices to drop to 4.78. In the upper region, resistance lies at 8.66. The next price resistance is at 10.24. RSI (Relative Strength Index) is 61.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.76, which suggests the price will decrease in the coming days. Percent R is at 44.08%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
